Cancer Alternative Therapy Clinical Trials

• Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003489 - Active, not recruiting
  Head and Neck Cancer
  
• Antineoplaston Therapy in Treating Patients With Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00003456 - Active, not recruiting
  adult glioblastoma
  
• Antineoplaston Therapy in Treating Women With Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003455 - Recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00080873 - Active, not recruiting
  Cancer; oral complications of cancer and cancer therapy
  
• Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003536 - Recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Antineoplaston Therapy in Treating Patients With Stage IV Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00003452 - Recruiting
  Recurrent Bladder Cancer; Stage IV Bladder Cancer
  
• IH636 Grape Seed Extract in Preventing Breast Cancer in Postmenopausal Women at Risk of Developing Breast Cancer
  ClinicalTrials.gov Identifier: NCT00100893 - Recruiting
  Breast Cancer
  
• Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003517 - Recruiting
  adenocarcinoma of the prostate; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
  
• Antineoplaston Therapy in Treating Patients With Colon Cancer
  ClinicalTrials.gov Identifier: NCT00003486 - Recruiting
  stage IV colon cancer; recurrent colon cancer; adenocarcinoma of the colon
  
• Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00003487 - Recruiting
  stage IV esophageal cancer; recurrent esophageal cancer; Adenocarcinoma of the Esophagus
  
• Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00003851 - Active, not recruiting
  stage II pancreatic cancer; stage III pancreatic cancer; stage IV pancreatic cancer; Nutrition; adenocarcinoma of the pancreas
  
• Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00003531 - Recruiting
  recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Antineoplaston Therapy in Treating Children With Brain Tumors
  ClinicalTrials.gov Identifier: NCT00003458 - Recruiting
  childhood brain tumor
  
• Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors
  ClinicalTrials.gov Identifier: NCT00003475 - Recruiting
  adult brain tumor
  
• Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003498 - Recruiting
  adult non-Hodgkin's lymphoma
  
• Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003492 - Recruiting
  recurrent non-small cell lung cancer; large cell lung cancer; stage IV non-small cell lung cancer
  
• Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin
  ClinicalTrials.gov Identifier: NCT00003526 - Recruiting
  adenocarcinoma of unknown primary; recurrent carcinoma of unknown primary
  
• Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer
  ClinicalTrials.gov Identifier: NCT00003453 - Recruiting
  stage IV adrenocortical carcinoma; recurrent adrenocortical carcinoma
  
• Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors
  ClinicalTrials.gov Identifier: NCT00003476 - Recruiting
  childhood brain tumor; childhood meningioma
  
• Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon Cancer
  ClinicalTrials.gov Identifier: NCT00003485 - Active, not recruiting
  stage IV colon cancer; recurrent colon cancer; adenocarcinoma of the colon
  
• Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003533 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Antineoplaston Therapy in Treating Women With Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003454 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Antineoplaston Therapy in Treating Patients With Ependymoma
  ClinicalTrials.gov Identifier: NCT00003479 - Active, not recruiting
  adult ependymoma; newly diagnosed childhood ependymoma; recurrent childhood ependymoma; adult anaplastic ependymoma
  
• Shark Cartilage Extract in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00005995 - Active, not recruiting
  Stage IV Renal Cell Cancer; Renal Cell Adenocarcinoma; recurrent renal cell cancer
  
• Herbal Therapy in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00028977 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Antineoplaston Therapy in Treating Patients With Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00003509 - Recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma
  ClinicalTrials.gov Identifier: NCT00003508 - Recruiting
  advanced malignant mesothelioma; recurrent malignant mesothelioma
  
• Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003534 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00088946 - Active, not recruiting
  transitional cell carcinoma of the bladder; stage 0 bladder cancer; stage I bladder cancer
  
• Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva
  ClinicalTrials.gov Identifier: NCT00003525 - Active, not recruiting
  stage IV cervical cancer; recurrent cervical cancer; stage IV vulvar cancer; recurrent vulvar cancer
  
• Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine
  ClinicalTrials.gov Identifier: NCT00003522 - Active, not recruiting
  small intestine adenocarcinoma; recurrent small intestine cancer
  
• Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Mixed Gliomas
  ClinicalTrials.gov Identifier: NCT00003473 - Recruiting
  recurrent adult brain tumor; Mixed Gliomas
  
• Antineoplaston Therapy in Treating Patients With Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00003524 - Active, not recruiting
  stage III gastric cancer; stage IV gastric cancer; recurrent gastric cancer; adenocarcinoma of the stomach
  
• Antineoplaston Therapy in Treating Patients With Primary Central Nervous System Lymphoma
  ClinicalTrials.gov Identifier: NCT00003505 - Recruiting
  primary central nervous system lymphoma
  
• Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma
  ClinicalTrials.gov Identifier: NCT00003470 - Recruiting
  recurrent adult brain tumor; adult anaplastic astrocytoma
  
• Mistletoe in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Are Receiving Palliative Chemotherapy
  ClinicalTrials.gov Identifier: NCT00052325 - Active, not recruiting
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Antineoplaston Therapy in Treating Patients With Residual or Recurrent Anaplastic Astrocytoma
  ClinicalTrials.gov Identifier: NCT00003537 - Recruiting
  recurrent adult brain tumor; adult anaplastic astrocytoma
  
• Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003516 - Active, not recruiting
  adenocarcinoma of the prostate; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
  
• Omeprazole and Amoxicillin and/or Vitamin and Mineral Supplements and/or Garlic Supplements in Preventing Stomach Cancer in Patients With Precancerous Stomach Lesions
  ClinicalTrials.gov Identifier: NCT00134121 - Active, not recruiting
  Gastric Cancer; Precancerous Condition
  
• Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System
  ClinicalTrials.gov Identifier: NCT00003469 - Recruiting
  childhood rhabdoid tumor of the central nervous system
  
• Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00003514 - Recruiting
  Merkel Cell Carcinoma; Islet Cell Carcinoma; Neuroendocrine Carcinoma; Pituitary Tumor
  
• Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma
  ClinicalTrials.gov Identifier: NCT00003472 - Recruiting
  recurrent adult brain tumor; adult anaplastic oligodendroglioma; Adult Oligodendroglioma
  
• Antineoplaston Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003497 - Active, not recruiting
  recurrent non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Antineoplaston Therapy in Treating Patients With Primary Liver Cancer
  ClinicalTrials.gov Identifier: NCT00003530 - Active, not recruiting
  stage IV childhood liver cancer; recurrent childhood liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer
  
• Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma
  ClinicalTrials.gov Identifier: NCT00003468 - Recruiting
  low-grade childhood cerebral astrocytoma; recurrent childhood cerebral astrocytoma
  
• Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003494 - Active, not recruiting
  recurrent non-small cell lung cancer; stage IV non-small cell lung cancer; Bronchoalveolar Cell Lung Cancer
  
• Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003495 - Active, not recruiting
  recurrent non-small cell lung cancer; Squamous Cell Lung Cancer; stage IV non-small cell lung cancer
  
• Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma
  ClinicalTrials.gov Identifier: NCT00003535 - Recruiting
  high-grade childhood cerebral astrocytoma; recurrent childhood cerebral astrocytoma
  
• Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003491 - Active, not recruiting
  recurrent non-small cell lung cancer; stage IV non-small cell lung cancer; Adenocarcinoma of the Lung
  
• Antineoplaston Therapy in Treating Patients With Brain Stem Glioma
  ClinicalTrials.gov Identifier: NCT00003459 - Active, not recruiting
  recurrent adult brain tumor; adult brain stem glioma; untreated childhood brain stem glioma; recurrent childhood brain stem glioma
  
• Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003496 - Active, not recruiting
  extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer
  
• Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00060086 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00003520 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer; Renal Cell Adenocarcinoma; ...
  
• Antineoplaston Therapy in Treating Children With Visual Pathway Glioma
  ClinicalTrials.gov Identifier: NCT00003477 - Recruiting
  untreated childhood visual pathway glioma; recurrent childhood visual pathway glioma
  
• Selenium and Vitamin E in Preventing Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00006392 - Active, not recruiting
  Prostate Cancer
  
• Antineoplaston Therapy in Treating Patients With Brain Tumors
  ClinicalTrials.gov Identifier: NCT00003457 - Recruiting
  ACTH-producing pituitary tumor; TSH producing pituitary tumor; adult brain tumor
  
• Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00053053 - Active, not recruiting
  adult solid tumor; Cachexia; Lymphoma
  
• Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003499 - Recruiting
  grade 1 follicular lymphoma; grade 2 follicular lymphoma; marginal zone lymphoma; Small Lymphocytic Lymphoma
  
• Hypericum Perforatum (St. John's wort) in Relieving Hot Flashes in Women With Non-Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00110136 - Recruiting
  Breast Cancer; breast cancer in situ; Hot Flashes
  
• Antineoplaston Therapy in Treating Children With Primitive Neuroectodermal Tumors
  ClinicalTrials.gov Identifier: NCT00003460 - Recruiting
  untreated childhood supratentorial primitive neuroectodermal tumors; recurrent childhood supratentorial primitive neuroectodermal tumors
  
• Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate
  ClinicalTrials.gov Identifier: NCT00078923 - Active, not recruiting
  stage I prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate
  
• Folate-Depleted Diet Compared With Folate-Supplemented Diet in Preventing Colorectal Cancer in Patients at High Risk for Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00096330 - Active, not recruiting
  Colon Cancer; Rectal Cancer
  
• Valeriana Officinalis (Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
  ClinicalTrials.gov Identifier: NCT00075842 - Active, not recruiting
  Sleep Disorders; unspecified adult solid tumor, protocol specific; Fatigue
  
• Omega-3 Fatty Acids in Preventing Breast Cancer in Women at High Risk of Developing Breast Cancer
  ClinicalTrials.gov Identifier: NCT00114296 - Active, not recruiting
  Breast Cancer
  
• American Ginseng in Treating Patients With Cancer-Related Fatigue
  ClinicalTrials.gov Identifier: NCT00182780 - Active, not recruiting
  Fatigue; unspecified adult solid tumor, protocol specific
  
• Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease
  ClinicalTrials.gov Identifier: NCT00031720 - Recruiting
  Breast Cancer; breast cancer in situ; Hot Flashes
  
• Lycopene in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00068731 - Active, not recruiting
  stage IV prostate cancer; recurrent prostate cancer
  
• Soy Protein Supplement in Preventing Prostate Cancer in Patients With Elevated Prostate-Specific Antigen Levels
  ClinicalTrials.gov Identifier: NCT00031746 - Active, not recruiting
  Prostate Cancer
  
• Antineoplaston Therapy in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00003511 - Recruiting
  refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00055705 - Completed
  Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; thorax and respiratory cancer; unclassified and other cancer
  
• Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00096356 - Recruiting
  Breast Cancer; Fatigue
  
• Green Tea Extract in Preventing Esophageal Cancer in Patients With Barrett''s Esophagus
  ClinicalTrials.gov Identifier: NCT00233935 - Recruiting
  Esophageal Cancer; Precancerous Condition
  
• Antineoplaston Therapy in Treating Patients With Meningioma
  ClinicalTrials.gov Identifier: NCT00003483 - Active, not recruiting
  recurrent adult brain tumor; adult malignant meningioma
  
• Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's Macroglobulinemia
  ClinicalTrials.gov Identifier: NCT00003512 - Active, not recruiting
  refractory plasma cell neoplasm; Waldenstrom's Macroglobulinemia
  
• Antineoplaston Therapy in Treating Patients With Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00003474 - Active, not recruiting
  recurrent adult brain tumor; adult glioblastoma multiforme
  
• Diet and PSA Levels in Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003367 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
  
• Fruit and Vegetable Extracts in Treating Patients With Stage I, Stage II, Stage III, Stage IVA, or Stage IVB Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00064298 - Recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
  
• Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00081211 - Completed
  Head and Neck Cancer
  
• Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00003532 - Active, not recruiting
  stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; stage III ovarian germ cell tumor; ...
  
• Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx
  ClinicalTrials.gov Identifier: NCT00004234 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; oral complications of cancer and cancer therapy; ...
  
• SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00026377 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate
  
• Vaccine Therapy and GM-CSF in Treating Patients With Prostate Cancer That Progressed After Surgery and/or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00108732 - Active, not recruiting
  recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• Levocarnitine in Treating Fatigue in Cancer Patients
  ClinicalTrials.gov Identifier: NCT00091169 - Active, not recruiting
  Fatigue; unspecified adult solid tumor, protocol specific
  
• Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00058006 - Active, not recruiting
  Head and Neck Cancer; thorax and respiratory cancer
  
• Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00070057 - Active, not recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
  
• Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy
  ClinicalTrials.gov Identifier: NCT00055718 - Active, not recruiting
  Drug Toxicity; childhood acute lymphoblastic leukemia
  
• Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00006359 - Active, not recruiting
  adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• Combination Chemotherapy and Filgrastim Followed by Radiation Therapy in Treating Patients With Stage II or Stage IIIA Breast Cancer
  ClinicalTrials.gov Identifier: NCT00007904 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer; Male Breast Cancer
  
• Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00060021 - Completed
  Cancer; oral complications of cancer and cancer therapy; Pain
  
• Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00003502 - Recruiting
  contiguous stage II mantle cell lymphoma; noncontiguous stage II mantle cell lymphoma; stage III mantle cell lymphoma; stage IV mantle cell lymphoma; ...
  
• Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00003513 - Active, not recruiting
  regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; recurrent neuroblastoma; localized unresectable neuroblastoma
  
• Radiation Therapy With or Without Epoetin alfa in Anemic Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00004917 - Active, not recruiting
  Anemia; Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
  
• Behavior-Based Dietary Intervention in Treating Patients With Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00082732 - Active, not recruiting
  stage I prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate
  
• Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00101062 - Active, not recruiting
  stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; recurrent breast cancer
  
• Soy Isoflavone Compared With No Treatment Before Surgery in Treating Patients With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00022269 - No longer recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIC breast cancer
  
• Isotretinoin, Interferon alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00054561 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
  
• Docetaxel With or Without Bevacizumab Followed by Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00027885 - Active, not recruiting
  stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; Male Breast Cancer
  
• Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00005970 - Active, not recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Bevacizumab and Combination Chemotherapy in Treating Patients Who Have Undergone Surgery for Breast Cancer That Has Spread to the Lymph Nodes
  ClinicalTrials.gov Identifier: NCT00119262 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; Male Breast Cancer
  
• Erlotinib and Bevacizumab in Treating Women With Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00054132 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer; Male Breast Cancer